Genprex
GNPX
8 hedge funds and large institutions have $510K invested in Genprex in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
20% more capital invested
Capital invested by funds: $426K → $510K (+$84.3K)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$293K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.7K |
| 3 |
BBHC
Brown Brothers Harriman & Co
New York
|
+$5.37K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.69K |
| 2 |
FGAM
Financial Gravity Asset Management
Lakeway,
Texas
|
-$62 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$33 |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$3 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2 |
GNPX Hedge Fund Activity: Q2 2024 in Review
8 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2024, worth a combined $510K — up 20% from $426K a quarter earlier.
Fund positioning in GNPX was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, adding an estimated $293K. The largest seller was UBS Group, exiting entirely with an estimated $2.69K sold.
- 8 institutional investors held Genprex (GNPX) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $510K of Genprex stock for Q2 2024, up 20% quarter-over-quarter.
- 1 fund opened new Genprex positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Genprex buyer in Q2 2024 was Armistice Capital, an estimated $293K added.
- The largest Genprex seller in Q2 2024 was UBS Group, an estimated $2.69K sold.
Based on aggregated 13F filings for Q2 2024.